Walleye Trading
MDGL icon

Walleye Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Walleye Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$52.3K – 4286
2026
Q1 		$52.3K Sell
100
-400
-80% -$191K ﹤0.01% 3666
2025
Q4 		$291K Sell
500
-1,300
-72% -$664K ﹤0.01% 3181
2025
Q3 		$826K Buy
+1,800
New +$672K ﹤0.01% 2398
2025
Q1 		– Sell
-1,700
Closed -$525K – 4457
2024
Q4 		$525K Buy
+1,700
New +$478K ﹤0.01% 2604
2024
Q2 		– Sell
-800
Closed -$214K – 4663
2024
Q1 		$214K Sell
800
-1,700
-68% -$401K ﹤0.01% 3384
2023
Q4 		$578K Buy
2,500
+1,900
+317% +$332K ﹤0.01% 2952
2023
Q3 		$87.6K Buy
600
+100
+20% +$18.8K ﹤0.01% 4024
2023
Q2 		$116K Buy
500
+200
+67% +$54.2K ﹤0.01% 3684
2023
Q1 		$72.7K Sell
300
-5,800
-95% -$1.58M ﹤0.01% 3967
2022
Q4 		$1.77M Sell
6,100
-84,300
-93% -$8.24M 0.01% 1784
2022
Q3 		$5.88M Buy
90,400
+82,600
+1,059% +$5.74M 0.02% 922
2022
Q2 		$558K Buy
7,800
+7,100
+1,014% +$522K ﹤0.01% 2790
2022
Q1 		$69K Buy
+700
New +$59K ﹤0.01% 4406
2020
Q4 		– Sell
-16,700
Closed -$1.98M – 4802
2020
Q3 		$1.98M Buy
16,700
+13,800
+476% +$1.5M 0.01% 1129
2020
Q2 		$328K Buy
+2,900
New +$285K ﹤0.01% 2633
2020
Q1 		– Sell
-2,500
Closed -$228K – 4321
2019
Q4 		$228K Buy
+2,500
New +$242K ﹤0.01% 3059
2019
Q2 		– Sell
-2,000
Closed -$251K – 4304
2019
Q1 		$251K Buy
+2,000
New +$249K ﹤0.01% 2856

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Walleye Trading's MDGL Position: Q2 2026 in Review

Walleye Trading increased its Madrigal Pharmaceuticals (MDGL) stake by 490% in Q2 2026, buying an estimated $203K and bringing the position to 478 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

Walleye Trading first reported a position in MDGL in Q3 2015 and has held it in 10 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Walleye Trading held 478 shares of Madrigal Pharmaceuticals worth $257K as of Q2 2026.
  • Walleye Trading bought 397 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $203K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3010 holding.
  • Walleye Trading first reported a position in Madrigal Pharmaceuticals in Q3 2015 and has held it in 10 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.